Latest Listings And Ipos News

Australian Dairy Nutritionals has secured firm commitments for a further A$1.54 million placement, taking its broader capital raise to A$2.04 million before costs. The funds are earmarked for operations, working capital and balance sheet support as the company prepares for FY27.

Emerald Resources delivered lower September-quarter production but generated A$112.4 million in pre-tax operating cash flow as its Cambodian mine sold gold at an average US$4,255 an ounce. The company kept FY27 guidance unchanged, advanced construction work at Dingo Range and Memot, and opened a potential US$400 million acquisition funding pathway.

Vitasora Health has signed a Florida healthcare agreement covering an initially addressable 9,000 Medicare patients while estimated October billable care minutes rose 50%. The ASX-listed company also agreed terms for an A$3 million secured facility, but the funding is not yet drawn and carries approval, interest and dilution conditions.

Ambertech has reported a $2.251 million FY26 statutory loss after taking about $3.2 million in goodwill, inventory and restructuring charges. Cash flow and inventory improved, but the ASX-listed technology distributor will not pay a final dividend as it turns FY27 into an execution test.

Nutritional Growth Solutions has cut quarterly net operating cash outflow by 54% while completing its Sprout Organic acquisition just after quarter end. The enlarged group starts with US$1.613 million in cash, no borrowings and a substantially larger share base.

Strickland Metals has ended the September quarter with a 9.25Moz AuEq resource at its Rogozna project, new geophysical targets in Serbia and A$75.7 million in cash and liquid investments. The next test is execution: drilling did not begin, licence approvals remain pending and a new managing director is yet to be appointed.

Tetragon Energy has entered its first full quarter as an ASX-listed explorer with $3.96 million in cash and an expanded plan to use seismic data to attract a farm-in partner. The company is also reassessing an onshore gas discovery that could support power generation in northern Luzon.

Nexalis Therapeutics ended September with $371,000 in cash, equivalent to just 0.9 quarters of funding at its recent operating burn. The company has settled its dispute with Linlithgow Family Office, but its clinical programs remain paused while it pursues R&D tax funding and a new capital raise.

Blackstone Minerals is moving through the pre-feasibility study for its large Mankayan copper-gold-silver project, with drilling discussions continuing and completion scheduled in FY27. The company ended September with $12.2 million in cash after using $1.6 million during the quarter, while several Vietnam milestones remain subject to government approvals.

Wiluna Mining has emerged from a disrupted September quarter with a $180 million IPO, no secured debt and a renewed exploration program. The transformation came after a CIL tank rupture halted processing, drove 91 redundancies and left the company with $18.7 million in cash at quarter end.

CAR Group enters FY27 with double-digit growth expectations after reporting A$1.253 billion in pro forma revenue and 100% EBITDA-to-cash conversion for FY26. Its next growth phase centres on AI agents, proprietary vehicle data and new products across its global marketplaces.

Australian Mines has told ASX it is unaware of undisclosed information behind a sharp increase in trading, while confirming that Boa Vista gold samples are still awaiting assay results. The company points instead to renewed scandium interest, promotional activity and its proposed corporate rebrand.